Drägerwerk Reports Preliminary Q3 EBIT of About €48M, Sales of €851M
Drägerwerk reported preliminary Q3 2026 EBIT of about €48M, including €20.1M in customs refunds, and net sales of about €851M, up 1% on a currency-adjusted basis. Order intake rose 7% to about €926M; the company confirmed its 2026 guidance for 2–6% sales growth and a 6–8% EBIT margin.